Primary Recipient

SEATTLE CHILDREN'S HOSPITAL

Amount

$2,355,329.00

Award Date

7/17/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Nonviral Gene Medicine for Hemophilia A -- The goal of this study is to develop a safe, efficient, and clinically feasible nonviral gene therapy strategy for the treatment of hemophilia A. Currently hemophilia A patients are treated with repeated infusio

Recipients Connected to Award

Recipient	Role	Amount
SEATTLE CHILDREN'S HOSPITAL	Primary recipient	$2,019,664.00
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON	Sub-recipient	$186,860.00
UNIVERSITY OF WASHINGTON	Sub-recipient	$148,805.00